Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies

Autor: Monagle, Paul, Robertson, Jeremy, Grangl, Gernot, Male, Christoph, Streif, Werner, Carniero, Jorge, Logetto, Sandra, Brandao, Leonardo, Halton, Jacqueline, Amedro, Pascal, Bonnet, Damien, Beyer-Westendorf, Jan, Dietrich, Sven, Holzhauer, Susanne, Nowak-Göttl, Ulrike, Kallay, Krisztian, Kenet, Gili, Revel-Vilk, Shoshana, Tamary, Hannah, Giordano, Paola, Abbattista, Maria, Artoni, Andrea, Molinari, Angelo C, Saracco, Paola, Simioni, Paolo, Tormene, Daniela, Ono, Hiroshi, Te Loo, Maroeska WM, Van Ommen, Heleen, Veening, Margreet A, Suiker, Monique H, Peters, Marjolein, Samochatova, Elena, Shamardina, Anastasia, Novgorod, Nizhny, Zubarovskaya, Lyudmila, Dasi, Maria A, Elorza, Maria, Santamaria, Amparo, Sánchez-Luna, Manuel, Albisetti, Manuela, Grunt, Sebastian, Kavakli, Kaan, Biss, Tina, Connor, Philip, Williams, Mike, Acharya, Suchitra, Bhat, Rumi, Kearney, Susan, Kumar, Riten, Patel, Kavita, Rajpukar, Madvi, Schwartz, Jeffrey H, Vik, Terry, Wynn, Tung, Yee, Donald L, Young, Guy, Lensing, Anthonie W A ^*, Thelen, Kirstin, Martinelli, Ida, Santamaría, Amparo, Connor, Phillip, Kapsa, Stefanie, Willmann, Stefan, Pap, Akos F, Becka, Michael, Twomey, Teresa, Prins, Martin H, Kubitza, Dagmar

Publikováno v: In The Lancet Haematology October 2019 6(10):e500-e509